MDRP 2025 Wrap-up

Salient topics and key takeaways from the MDRP 2025 conference.

MFN Executive Order Update

Interpretation of the evolving demands from the administration, and recommendations for manufacturers.

Inc. 5000 Fastest-Growing Company

We've been named one of Inc. 5000 fastest-growing companies.

340B Rebate Model Pilot Program

The pilot includes 10 drugs and is soliciting manufacturer comments.

The New Medicare P Code Process

Starting in 2026, manufacturers can gain a P Code on a quarterly basis.

Most-Favored-Nation Executive Order

Proposed actions manufacturers can take in light of the MFN Executive Order.

Woven Data Announces a New Analytical Capability to Answer What-if Questions

Cloning the entire analytical environment to explore potential changes.

Insights from the Q1 Medicare MDP Rebate Processing Cycle

A recap of emerging Medicare MDP trends.

Tariffs and the Pharma Industry

Scenario planning for tariffs on pharmaceuticals.

VA FSS: US-Made Products

New "Made in America" policies and potential actions required to mark products as "US-Made."

2025 GP Calendar

Add the 2025 GP Calendar to your Outlook or Google Calendar.

Medicaid Rebates and the AMP Cap Removal – Building Your Internal Analytics

Stay on top of changes like the AMP cap removal.

2025 Public Law

Key dates and documents for the VA 2025 Public Law.

Medicare Updates & Notes for Manufacturers

Key dates and requirements from the recent CMS Medicare implementation memos.

IRA Negotiations Round 1

Thoughts on the first round of the Inflation Reduction Act drug price negotiations.

2025 Annual Public Law Preparation

VA has begun preparations for the 2025 Public Law. Here is what you need to get started.

Reimbursement Rules with Zero or Negative ASP

CMS rules published as part of the Physician Fee Schedule for 2025.

Authorized Generics

What the Authorized Generics are, and how they are treated in Government Pricing calculations and commercially.

The impacts of PBMs according to the FTC

Observations from the FTC report on the impact of PBMs on drug pricing.

IFF Sales Reporting Portal and Credit Disclaimers

The new IFF reporting portal is up.

IFF Overview and New Operational Challenges

The Q4 2023 GP reporting cycle was the first quarter with the shortened IFF reporting & payment requirements in effect.

2024 GP Calendar

Add the 2024 GP Calendar to your Outlook or Google Calendar.

Phase-In of Medicare Part D Rebates

IRA defines gradually increasing rebate rates that will apply in various manufacturer scenarios.

Transition from CGDP to the new Part D Manufacturer Discount Program

The IRA sunsets CGDP as of 1/1/2025. The deadline to enter the new Part D Program agreement for 2025 is March 1, 2024.

Final CMS Guidance for the Part D Manufacturer Discount Program

Let's review the key Medicare Part D manufacturer rebate program changes.

Changes to the administration of the Industrial Funding Fee (IFF)

IRA Coinsurance Adjustments

After receiving industry feedback, including ours, CMS has corrected the calculation of the coinsurance adjustment percentage for several products.

Meet us at Asembia in Las Vegas

Lisa and Scott will be at the Asembia specialty pharmacy summit.

Congratulations on the Leadership Award, Dave!

Dave received the Distribution Management Award for Industry Leadership from the HDA.

Are you ready for SAM changes?

Medicaid & GP Congress May 16-18

Jennifer Katona, our Partner, Client Services is moderating a Medicaid Automation session at the Medicaid & GP Congress.

CMS Guidance for Inflation Rebates

CMS released its initial guidance for the implementation of the Medicare Part B and Part D Prescription Drug Inflation Rebates.

2023 GP Calendar

Download the 2023 GP Calendar and never miss a deadline!

What is Your Government Pricing Story?

Effectively telling Your GP story to various stakeholders is an art. Here are the key considerations to keep in mind.

Visit us at MDRP Chicago Oct 12-14

Visit our booth at MDRP Chicago Oct 12-14, and come by Scott's session on Accuracy of Inputs into GP Calculations.

Welcome Lisa Arthurs as VP of Sales & New Business Development

We're delighted to welcome Lisa Arthurs as Vice President, Sales & New Business Development. Lisa has joined to drive the adoption of our services and technology across the pharma manufacturer industry.

SOC 1 Type 2 Certification

We received a SOC 1 Type 2 certification. The audit examined our managed service practices and security, and confirmed that we serve our clients reliably and safely.

Meet us at the Medicaid & GP Congress in May

We are going to be at the Medicaid & GP Congress in Philadelphia, and Scott is speaking on there on May 24th. Our team looks forward to meeting you at the event!

MDRP 2021 Coming Up

MDRP 2021 is happening in person October 11-13. Scott Hoffman is speaking at a couple of sessions. Come by and say hello!

Best Practices: Accrual of Government Rebate and Chargeback Liabilities

A playbook for when it's time for you to update accruals around all your government financial liabilities.

Meet us at Medicaid and Government Pricing Congress

Scott is moderating a Product Launch, Divestiture, and Acquisition Challenges workshop on June 8.

Overview for Government Contracting

One of the steps in launching or acquiring your first product is deciding on government contracting. Fortunately, once you know the requirements, this can be straightforward.

BP and the True-up Process

In this post I focus on Best Price and the BP True-up. We look at a couple of factors to consider when establishing your BP methodology and the True-up process.

Sunset of the AMP Medicaid Rebate Cap

The Senate recently passed H.R. 1319, the $1.9T stimulus package. Amongst many changes to Medicaid, the new legislature ends the AMP cap for Unit Rebate Amounts.

An Intro to GTN

An introduction to the three key components of gross to net modeling: market access channels, stacking, and the pricing strategy.

SOC 1 Certification

We are happy to share that we just received a SOC 1 Type 1 certification. The SOC audit examined our managed service policies and procedures, and our platform security and reliability practices, to ensure that we serve our clients reliably and safely.

True Payer Mix

At Woven Data, we use a concept of "True Payer Mix", which is instrumental at all stages of the product life cycle, from acquisition due diligence, commercialization, to ongoing brand management.

Welcome, and let us introduce ourselves!

Our goal at Woven Data is to provide analytical tools and managed services to drive commercial success for pharmaceutical manufacturers. In this blog, we'll be covering our experiences in all of the areas that we touch: market access, government pricing, contracting, and M&A diligence and reporting. You will be seeing my name on many of these posts, so I figure this is as good a time as any to introduce myself.